Telemus Capital’s AstraZeneca AZN Stock Holding History

Telemus Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$642K	Buy	4,767 +290	+6%	+$37.7K	0.05%	208
2023 Q3	$606K	Buy	4,477 +521	+13%	+$71.2K	0.06%	197
2023 Q2	$566K	Buy	3,956 +1,029	+35%	+$151K	0.05%	212
2023 Q1	$406K	Sell	2,927 -84	-3%	-$11.3K	0.04%	238
2022 Q4	$426K	Buy	3,011 +40	+1%	+$5.02K	0.04%	238
2022 Q3	$326K	Buy	+2,971	New	+$377K	0.03%	242
2016 Q4	–	Sell	-4,347	Closed	-$286K	–	307
2016 Q3	$286K	Sell	4,347 -1,946	-31%	-$127K	0.03%	282
2016 Q2	$380K	Sell	6,293 -111	-2%	-$6.45K	0.05%	243
2016 Q1	$361K	Buy	+6,404	New	+$385K	0.06%	229

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Telemus Capital's AZN Position: Q4 2023 in Review

Telemus Capital increased its AstraZeneca (AZN) stake by 6.5% in Q4 2023, buying an estimated $37.7K and bringing the position to 4,767 shares worth $642K. The position accounts for 0.05% of the portfolio, ranked #208.

Telemus Capital first reported a position in AZN in Q1 2016 and has held it in 9 quarters since. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

Telemus Capital held 4,767 shares of AstraZeneca worth $642K as of Q4 2023.
Telemus Capital bought 290 AstraZeneca shares in Q4 2023, an estimated $37.7K.
AstraZeneca made up 0.05% of Telemus Capital's portfolio in Q4 2023, its #208 holding.
Telemus Capital first reported a position in AstraZeneca in Q1 2016 and has held it in 9 quarters since.
1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.